NCT00003623 - High-Dose Multivitamins Compared to a Placebo in Preventing the Recurrence of Cancer in Patients With Early Stage Bladder Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 31, 1999

Primary Completion Date

March 31, 2003

Study Completion Date

March 31, 2003

Conditions

Bladder Cancer

Interventions

DIETARY_SUPPLEMENT

multivitamin

OTHER

Placebo

Trial Locations (17)

48106

CCOP - Ann Arbor Regional, Ann Arbor

55805

CCOP - Duluth, Duluth

55905

Mayo Clinic Cancer Center, Rochester

56303

CentraCare Clinic, Saint Cloud

57709

Rapid City Regional Hospital, Rapid City

58122

CCOP - Merit Care Hospital, Fargo

58201

Altru Health Systems, Grand Forks

58501

Medcenter One Health System, Bismarck

61801

CCOP - Carle Cancer Center, Urbana

85259-5404

CCOP - Scottsdale Oncology Program, Scottsdale

52403-1206

CCOP - Cedar Rapids Oncology Project, Cedar Rapids

50309-1016

CCOP - Iowa Oncology Research Association, Des Moines

51101-1733

Siouxland Hematology-Oncology, Sioux City

67214-3882

CCOP - Wichita, Wichita

43623-3456

CCOP - Toledo Community Hospital Oncology Program, Toledo

57105-1080

CCOP - Sioux Community Cancer Consortium, Sioux Falls

S4T 7T1

Allan Blair Cancer Centre, Regina

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Alliance for Clinical Trials in Oncology

OTHER